The methods of prophylaxis of the morbidity occurrence after pancreatico-duodenal resection

Keywords: sarcopenia; pancreaticoduodenal resection; scale of the risk for the pancreatic fistula occurrence.

Abstract

Objective. To elaborate the system of measures with objective of lowering of the occurrence rate for pancreatic fistula and severe complications after pancreaticoduodenal resection (PDR).

Маterials and methods. Results of treatment was analyzed for 143 patients, to whom pancreaticoduodenal resection performed. In accordance to the scheme proposed, using elaborated scale of the risk for occurrence of postoperative pancreatic fistula, were operated 56 patients in 2017 - 2018 yrs (the main group). Comparative group consisted of 87 patients, operated in the clinic in 2015 - 2016 yrs without estimation of the risk for postoperative pancreatic fistula occurrence and sarcopenia presence, and formation of pancreaticojejunoanastomosis have depended upon decision of a surgeon-operator.

Results. The rate of occurrence of the postoperative complications was trustworthily higher in the comparison group (c2 = 5.8, p=0.01). In the main group a clinically significant pancreatic fistula of Grade В was observed in 1 of 7 patients with postoperative complications. In the comparison group pancreatic fistulas of Grades В or С were diagnosed in 15 of 26 patients with postoperative complications, which are trustworthily higher, than in the main group (c2 = 4.16, p=0.04).

Conclusion. The system of measures elaborated gave the possibility to reduce the occurrence rate for pancreatic fistula significantly - from 17.2 tо 1.8% and severe postoperative morbidity - from 29.9 tо 12.5%.

Author Biographies

V. М. Коpchak, Shalimov National Institute of Surgery and Transplantology, Kyiv

Kopchak Volodymyr Mykhailovych, DSci, Professor.
Head of the Department of Pancreatic and Bile Ducts Surgery.
Shalimov National Institute of Surgery and Transplantology,
30 Heroyv Sevastopolya Str., c. Kyiv, 03680, Ukraine.
044 454 20 09.
vmkopchak@gmail.com.
https://orcid.org/0000-0003-0134-7500

L. О. Pererva, Shalimov National Institute of Surgery and Transplantology, Kyiv

Pererva Liudmyla Oleksandrovna, PhD. Scientific researcher
Department of Pancreatic and Bile Ducts Surgery.
Shalimov National Institute of Surgery and Transplantology,
30 Heroyv Sevastopolya Str., c. Kyiv, 03680, Ukraine.
044 454 20 09.
perervalunet@bigmir.net.
https://orcid.org/0000-0002-4030-1030

О. V. Duvalko, Shalimov National Institute of Surgery and Transplantology, Kyiv

Duvalko Olexandr Vasylovych, PhD. Senior Researcher
Department of Pancreatic and Bile Ducts Surgery.
Shalimov National Institute of Surgery and Transplantology,
30 Heroyv Sevastopolya Str., c. Kyiv, 03680, Ukraine.
044 454 20 09.
A.duvalko@gmail.com.
https://orcid.org/0000-0001-7423-916X

V. V. Khanenko, Shalimov National Institute of Surgery and Transplantology, Kyiv

Khanenko Vasiliy Vasiliyovich
Department of Pancreatic Surgery, Laparoscopic and Reconstructive Surgery of Bile Ducts. Shalimov National Institute of Surgery and Transplantology,
Shalimov National Institute of Surgery and Transplantology,
30 Heroyv Sevastopolya Str., c. Kyiv, 03680, Ukraine.
044 454 20 09
Vasilkhan@mail.ru
https://orcid.org/0000-0003-4548-0039

S. V. Аndronik, Shalimov National Institute of Surgery and Transplantology, Kyiv

Andronik Serhii Vasylovych, surgeon
Department of Pancreatic Surgery, Laparoscopic and Reconstructive Surgery of Bile Ducts. Shalimov National Institute of Surgery and Transplantology,
30 Heroyv Sevastopolya Str., c. Kyiv, 03680, Ukraine.
044 454 20 09.
Serg.andronik@gmail.com.
https://orcid.org/0000-0003-2291-4199

S. V. Suhachov, Shalimov National Institute of Surgery and Transplantology, Kyiv

Suhachov Sergii Victorovych,
Head of the Department of CT, MRI and X-ray.
Shalimov Institute of Surgery and Transplantology,
30 Heroyv Sevastopolya Str., Kyiv, 03680, Ukraine.
svsctmrt@ukr.net
https://orcid.org/0000-0002-6650-8152

V. О. Кropyvnytskyi, Shalimov National Institute of Surgery and Transplantology, Kyiv

Kropyvnytskyi V.O.
Head of Pathology department,
Shalimov National Institute of Surgery and Transplantology,
National Academy of Medical Sciences of Ukraine,
30 Heroyv Sevastopolya Str., c. Kyiv, 03680, Ukraine.
Vlad.kropelnytskyi@gmail.com / 0683592268
https://orcid.org/0000-0002-6390-6219

References

Hartwig W, Gluth A, Hinz U, Koliogiannis D, Strobel O, Hackert T, et al. Outcomes after extended pancreatectomy in patients with borderline resectable and locally advanced pancreatic cancer. Br J Surg. 2016;103(12):1683-94. doi: 10.1002/bjs.10221.

Kaiser J, Hackert T, Buchler MW. Extended Pancreatectomy: Does It Have a Role in the Contemporary Management of Pancreatic Adenocarcinoma? Dig Surg. 2017;34:441-6. doi: 10.1159/000478539.

Petrucciani N, Debs T, Nigri G, Giannini G, Sborlini E, Kassir R, et al. Pancreatectomy combined with multivisceral resection for pancreatic malignancies: is it justified? Results of a systematic review. HPB. 2017,1-8. doi: 10.1016/j.hpb.2017.08.002.

He J, Page AJ, Weiss M, Wolfgang CL, Herman JM, Pawlik TM. Management of borderline and locally advanced pancreatic cancer: where do we stand? World J Gastroenterol 2014; March 7;20(9):2255-66. doi: 10.3748/wjg.v20.i9.2255.

Callery MP, Pratt WB, Kent TS, Chaikof EL, Vollmer CM Jr. A prospectively validated clinical risk score accurately predicts pancreatic fistula after pancreatoduodenectomy. J Am Coll Surg 2013;216(1):1-14. doi: 10.1016/j.jamcollsurg.2012.09.002.

Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age and Ageing. 2010; 39:412-23. doi:10.1093/ageing/afq034.

Joglekar S, Asghar A, Mott SL, Johnson BE, Button AM, Clark E, et al. Sarcopenia Is an Independent Predictor of Complications Following Pancreatectomy for Adenocarcinoma. Iowa J Surg Oncol. 2015;111(6):771-5. doi:10.1002/jso.23862.

Peng P, Hyder O, Firoozmand A, Kneuertz P, Schulick RD, Huang D, et al. Impact of Sarcopenia on Outcomes Following Resection of Pancreatic Adenocarcinoma. J Gastrointest Surg. 2012 August;16(8):1478-86. doi:10.1007/s11605-012-1923-5.

Amini N, Spolverato G, Gupta R, Margonis GA, Kim Y, Wegner D, et al. Impact of Total Psoas Volume on Short- and Long- Term Outcomes in Patients Undergoing Curative Resection for Pancreatic Adenocarcinoma: a New Tool to Assess Sarcopenia. J Gastrointest Surg. 2015;19(9):1593-602. doi:10.1007/s11605-015-2835-y.

Takagi K, Yoshida R, Yagi T, Umeda Y, Nobuoka D, Kuise T, et al. Radiographic sarcopenia predicts postoperative infectious complications in patients undergoing pancreaticoduodenectomy. BMC Surgery 2017;17:64. doi 10.1186/s12893-017-0261-7.

Namm JP, Thakrar KH, Wang CH, Stocker SJ, Sur MD, Berlin J, et al. A semi-automated assessment of sarcopenia using psoas area - and density predicts outcomes after pancreaticoduodenectomy - for pancreatic malignancy. J Gastrointest Oncol 2017;8(6):936-44. doi: 10.21037/jgo.2017.08.09.

Yoh K, Nishikawa H, Enomoto H, Ishii N, Iwata Y, Ishii A, et al. Effect of exercise therapy on sarcopenia in pancreatic cancer: a study protocol for a randomised controlled trial. BMJ Open Gastro. 2018;5:e000194. doi:10.1136/bmjgast-2017-000194.

Dionyssiotis Y, Kapsokoulou A, Samlidi E, Angoules A, Papathanasiou J, Chronopoulos E, et al. Sarcopenia: From definition to treatment. Hormones (Athens). 2017 Oct;16(4):429-439. doi: 10.14310/horm.2002.1764.

Published
2019-05-05
How to Cite
КоpchakV. М., PerervaL. О., DuvalkoО. V., Khanenko, V. V., АndronikS. V., Suhachov, S. V., & КropyvnytskyiV. О. (2019). The methods of prophylaxis of the morbidity occurrence after pancreatico-duodenal resection. Klinicheskaia Khirurgiia, 86(5), 3-7. https://doi.org/10.26779/2522-1396.2019.05.03
Section
General Problems of Surgery